This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 27 PubMed articles · model: gemma4:31b
Summary
Comfrey (Symphytum officinale) is a traditional medicinal plant used topically for inflammation and pain, though its internal use is restricted due to severe hepatotoxicity [PMID:30000832, PMID:41993578].
Background
Symphytum officinale, commonly known as comfrey, is a perennial plant that has been used in traditional medicine for over 2,000 years [PMID:41993578, PMID:21170807].
Traditional uses
In folk medicine, comfrey root has been used to treat swellings, phlebitis, contusions, gastro-duodenal ulcers, respiratory diseases, metrorrhagia, wounds, fractures, and inflammatory conditions [PMID:37506778, PMID:41993578].
Active compounds
Key bioactive constituents include allantoin, rosmarinic acid, pyrrolizidine alkaloids (PAs) such as lycopsamine and intermedine, polysaccharides, lignans, and various phenolic acids and flavonoids [PMID:30000832, PMID:41993578, PMID:21170807, PMID:38252561].
Mechanism of action
Comfrey exerts anti-inflammatory and tissue-regenerative effects primarily by inhibiting NF-κB and MAPK pathways and suppressing pro-inflammatory markers including E-selectin, VCAM1, ICAM1, and COX-2 [PMID:41993578, PMID:31105555].
Clinical evidence
Evidence BPain, inflammation, and swelling of muscles and joints (degenerative arthritis, acute back myalgia, sprains, contusions, strains)
Multiple randomized controlled trials have demonstrated the efficacy and safety of topical comfrey preparations for these conditions, including in children aged 3 or 4 and over [PMID:22359388, PMID:23224633]
Evidence CPost-episiotomy pain and cracked nipples
Scientific evidence of effectiveness for these indications is minimal [PMID:30000832]
Safety & adverse effects
Pyrrolizidine alkaloids in comfrey can cause severe liver damage, liver cancer, mutagenicity, and death [PMID:30000832]. These alkaloids are potentially hepatotoxic, pneumotoxic, genotoxic, and carcinogenic, interacting with DNA in liver endothelial cells and hepatocytes [PMID:26177929, PMID:21170807]. Due to these risks, the U.S. FDA has banned the sale of oral comfrey products [PMID:30000832].
Pregnancy & lactation
Topical use of comfrey during breastfeeding is considered contraindicated by most sources; if used, it should be applied to intact skin away from the breast for a limited duration to ensure the infant does not come into direct contact with the area [PMID:30000832].
Evidence summary
Strong clinical evidence (RCTs) supports the topical use of comfrey for musculoskeletal pain and inflammation, while strong toxicological evidence supports the prohibition of internal use due to hepatotoxicity.
PubMed sources
1.PMID: 30000832 (2006) — The efficacy and safety of comfrey. · Public health nutrition
2.PMID: 22359388 (2012) — Comfrey: a clinical overview. · Phytotherapy research : PTR
3.PMID: 37506778 (2024) — Skin microbiota metabolism of natural products from comfrey root (Symphytum officinale L.). · Journal of ethnopharmacology
4.PMID: 38252561 (2024) — Phytochemical profiling and bioactivity assessment of underutilized Symphytum species in comparison with Symphytum officinale. · Journal of the science of food and agriculture
5.PMID: 41993578 (2026) — Ethnopharmacological insights into Symphytum officinale L.: traditional uses, phytochemical composition, therapeutic potential, and clinical-toxicological implications.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 26177929 (2016) — The comparative toxicity of a reduced, crude comfrey (Symphytum officinale) alkaloid extract and the pure, comfrey-derived pyrrolizidine alkaloids, lycopsamine and intermedine in chicks (Gallus gallus domesticus). · Journal of applied toxicology : JAT
7.PMID: 23224633 (2013) — Comfrey root: from tradition to modern clinical trials. · Wiener medizinische Wochenschrift (1946)
8.PMID: 31105555 (2019) — A Symphytum officinale Root Extract Exerts Anti-inflammatory Properties by Affecting Two Distinct Steps of NF-κB Signaling. · Frontiers in pharmacology
9.PMID: 21170807 (2010) — Metabolism, genotoxicity, and carcinogenicity of comfrey. · Journal of toxicology and environmental health. Part B, Critical reviews